SUBSCRIBERS
Big Pharma losing price leverage amid squeeze by payers
Latest quarterly results raise pressure on drugmakers to pump up sales volumes, find lucrative new treatments
Add BT as a preferred sourcePublished Thu, May 4, 2017 · 09:50 PM
New York
BEING a big drug company isn't what it used to be.
The largest drugmakers are finding it more difficult to charge high prices for a range of medications, their latest quarterly results show. That's raising the pressure to pump up sales volumes and find lucrative new treatments for niche markets.
Share with us your feedback on BT's products and services
